News » December, 2010 » 21 December 2010
Survival in pharmaceutical sector: 25% growth next year
21.12.2010, 00:03 | Business | 862 views
Labormed drug producer, owned by Advent International investment fund, has budgeted a 25% turnover increase for 2011 from the 70-75m-euro level reached this year. "2011 will be another year of survival. The strategy we have to survive is growth. There are two ways one can carry on in such an environment. Cutting costs and the business size as much as possible, but this strategy would not work in our case. The second solution would be to grow and this is what we've chosen for Labormed," Stephen Stead told ZF. Read more on ZF.ro
|
Latest news in category Business
The volume of construction works dropped to six months by 10.2%, as gross series, taking into account the drops in capital repairs' works, by 18.4%, and in the maintenance and current repairs, by 12%, and as adjusted series after the number of working days and seasonality dropped by 9.4%, according to the National Institute of Statistics. read more...
The National Salt Company - Salrom SA last year achieved a profit of 38.7 million lei, up 86% over 2012, said Alina Floroian, marketing economist with the company. The turnover of Salrom reached 308.3 million lei, up 13% over 2012, she said. read more...
Anca Vlad, the CEO of Catena Grup, is an ardent supporter of entrepreneurial spirit and thinks that you can't have a successful business without taking risks. read more...
|
|
